Optimizing locomotion techniques in virtual reality: a comparative analysis of posture, interaction freedom, and methods
The Visual Computer · 2025-11 · 41 (14) · 11959-11975
DOI: 10.1007/s00371-025-04137-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Visual Computer, online erschienen am 23.08.2025. Verfasst von Jie Hao und 7 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Gefördert von: National Key Research and Development Program of China, 2022 major science and technology project “Yuelu·Multimodal Graph-Text-Sound-Semantic Gesture Big Model Research and Demonstration Application” in Changsha, Beijing Chaoyang Internet 3.0 Key Core Technology R&D Project.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Key Research and Development Program of China
- 2022 major science and technology project “Yuelu·Multimodal Graph-Text-Sound-Semantic Gesture Big Model Research and Demonstration Application” in Changsha
- Beijing Chaoyang Internet 3.0 Key Core Technology R&D Project
Zitieren
APA
Hao, J., Du, Q., Li, M., Liang, B., Weng, D., Guo, J., Liu, Y., & Wang, Y. (2025). Optimizing locomotion techniques in virtual reality: a comparative analysis of posture, interaction freedom, and methods. The Visual Computer, 41(14), 11959-11975. https://doi.org/10.1007/s00371-025-04137-8
Vancouver
Hao J, Du Q, Li M, Liang B, Weng D, Guo J, et al. Optimizing locomotion techniques in virtual reality: a comparative analysis of posture, interaction freedom, and methods. The Visual Computer. 2025;41(14):11959-11975. doi:10.1007/s00371-025-04137-8
BibTeX
@article{Hao2025,
author = {Hao, Jie and Du, Qiuxin and Li, Ming and Liang, Bin and Weng, Dongdong and Guo, Jie and Liu, Yue and Wang, Yongtian},
title = {Optimizing locomotion techniques in virtual reality: a comparative analysis of posture, interaction freedom, and methods},
journal = {The Visual Computer},
year = {2025},
volume = {41},
number = {14},
pages = {11959--11975},
doi = {10.1007/s00371-025-04137-8}
}
EUVIMED